Huibin Zhang

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 4

Top Topics

Molecular Dynamics Simulations

Squamous Cell Carcinoma

Structure Activity Relationship

Top Venues

Journal of medicinal chemistry

Molecular diversity

This page only lists publications with an associated author ORCID identifier.

Publications

Xinrui Yuan, Dezhong Guan, Chao Chen, Shi Guo, Hanshu Wu, Hong Bu, Chao-Yie Yang, Mian Wang, Jinpei Zhou, Huibin Zhang
Development of an Imidazopyridazine-Based MNK1/2 Inhibitor for the Treatment of Lymphoma. Journal of medicinal chemistry 67 (7) (2024)
Xinrui Yuan, Dezhong Guan, Chao Chen, Shi Guo, Hanshu Wu, Hong Bu, Chao-Yie Yang, Mian Wang, Jinpei Zhou, Huibin Zhang
Development of an Imidazopyridazine-Based MNK1/2 Inhibitor for the Treatment of Lymphoma. Journal of medicinal chemistry 67 (7) (2024)
Xinrui Yuan, Dezhong Guan, Chao Chen, Shi Guo, Hanshu Wu, Hong Bu, Chao-Yie Yang, Mian Wang, Jinpei Zhou, Huibin Zhang
Development of an Imidazopyridazine-Based MNK1/2 Inhibitor for the Treatment of Lymphoma. Journal of medicinal chemistry (2024)
Peiyu Zhu, Jian Zhang, Yifei Yang, Lixun Wang, Jinpei Zhou, Huibin Zhang
Design, synthesis and biological evaluation of isoxazole-containing biphenyl derivatives as small-molecule inhibitors targeting the programmed cell death-1/ programmed cell death-ligand 1 immune checkpoint. Molecular diversity (2021)